A RANDOMIZED, PLACEBO-CONTROLLED, CROSS-OVER TRIAL INVESTIGATING NABILONE AS A TREATMENT FOR AGITATION IN PATIENTS WITH MODERATE-TO-SEVERE ALZHEIMER'S DISEASE: BLINDED, INTERIM SAFETY RESULTS
Ruthirakuhan, Myuri, Herrmann, Nathan, Abraham, Eleenor H., Sherman, Chelsea, Verhoeff, Nicolaas Paul L.G., Kiss, Alex, Black, Sandra E., Andreazza, Ana C., Lanctot, Krista L.Volume:
13
Language:
english
Journal:
Alzheimer's & Dementia
DOI:
10.1016/j.jalz.2017.06.1867
Date:
July, 2017
File:
PDF, 218 KB
english, 2017